Financials Fresh2 Group Limited

Equities

FRES

US03635R2067

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.5787 USD -3.55% Intraday chart for Fresh2 Group Limited +57.13% -34.98%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 387.4 123.2 65.83
Enterprise Value (EV) 1 395.7 145.6 74.63
P/E ratio -4.81 x -0.89 x -0.61 x
Yield - - -
Capitalization / Revenue 18.9 x 6.85 x 5.47 x
EV / Revenue 19.3 x 8.1 x 6.2 x
EV / EBITDA -4.39 x -1.43 x -0.94 x
EV / FCF -11,875,793 x -4,295,502 x -3,104,424 x
FCF Yield -0% -0% -0%
Price to Book 141 x -27.5 x -8.33 x
Nbr of stocks (in thousands) 560 795 2,039
Reference price 2 691.7 155.0 32.28
Announcement Date 4/30/21 5/16/22 5/16/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 5.686 10.25 10.84 20.51 17.99 12.04
EBITDA 1 -38.92 -40.72 -86.45 -90.06 -102.2 -79.46
EBIT 1 -40.92 -43.61 -89.08 -93.13 -106 -84.14
Operating Margin -719.72% -425.45% -821.41% -454.07% -589.6% -698.59%
Earnings before Tax (EBT) 1 -39.31 -42.5 -101.8 -80.65 -121.3 -105.7
Net income 1 -39.08 -42.06 -101.1 -80.48 -118.7 -101.9
Net margin -687.23% -410.37% -931.86% -392.39% -659.93% -846.01%
EPS 2 -98.46 -98.69 -226.1 -143.8 -174.5 -53.29
Free Cash Flow - -17.93 -25.21 -33.32 -33.9 -24.04
FCF margin - -174.92% -232.45% -162.46% -188.5% -199.59%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 9/20/19 9/20/19 5/15/20 4/30/21 5/16/22 5/16/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 4.17 40.9 34.6 8.32 22.5 8.8
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.107 x -1.005 x -0.4007 x -0.0924 x -0.2198 x -0.1107 x
Free Cash Flow - -17.9 -25.2 -33.3 -33.9 -24
ROE (net income / shareholders' equity) - 656% 530% 1,274% -5,227% 2,562%
ROA (Net income/ Total Assets) - -48.3% -105% -113% -113% -97.4%
Assets 1 - 87.13 95.97 71.12 105.1 104.6
Book Value Per Share 2 22.40 -52.10 -32.40 4.890 -5.630 -3.870
Cash Flow per Share 2 26.80 30.00 12.40 5.000 11.60 0.5300
Capex 1 2.6 2.42 2.79 2.47 3.9 1.46
Capex / Sales 45.8% 23.58% 25.73% 12.02% 21.68% 12.1%
Announcement Date 9/20/19 9/20/19 5/15/20 4/30/21 5/16/22 5/16/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. FRES Stock
  4. Financials Fresh2 Group Limited